Akero Therapeutics

Price & Volume

Stats

Open	$45.25
Previous Close	$45.08
Day Range	$43.90-$45.25
52W Range	$17.86-$58.40
Market Cap	$3.5B
Shares Short	4M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$3.75

News

Yahoo Finance • yesterday

Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is Investigating Claims on Your Behalf

Yahoo Finance • 26 days ago

Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Yahoo Finance • 26 days ago

Is Akero Therapeutics Inc. (AKRO) the Best Performing Mid Cap Stock to Buy According to Analysts?

Yahoo Finance • last month

Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Akero Therapeutics, Inc. (NASDAQ: AKRO); Crocs, Inc. (NASDAQ: CROX); Extreme Networks, Inc. (NASDAQ: EXTR); and Domino’s Pizza Corp. (NASDAQ: DPZ)

About

CEO	Dr. Andrew Cheng M.D., Ph.D.
CFO	Mr. William R. White J.D.
Address	601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	63